Share Prices & Company Research

Stockbroking

Indivior

Current Price 206.85p Bid 202.30p Ask 202.80p Change -1.80%
Last Updated: 16/11/2018 18:40. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Indivior plc is a global specialty pharmaceutical company with a 20-year legacy of leadership in patient advocacy and health policy while providing education on evidence-based treatment models that have revolutionized modern addiction treatment. The name is the fusion of the words individual and endeavour, and the tagline Focus on you makes the Company's commitment clear. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid dependence treatments, Indivior has a strong pipeline of product candidates designed to both expand on its heritage in this category and address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder and schizophrenia. Headquartered in the United States in Richmond, VA, Indivior employs more than 900 individuals globally and its portfolio of products is available in over 40 countries worldwide.

Financial Highlights Year Ended 31/12/2017

Turnover
£1,093.00m
Operating Profit
£193.00m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
25.75

Key Personnel

Shaun Thaxter
Chief Executive Officer
Mark Wesley Crossley
Chief Financial Officer
Howard H Pien
Executive Chairman
Lorna Mary Southcombe Parker
Non-Executive Director
Daniel Joseph Phelan
Non-Executive Director
Lizabeth Herbst Zlatkus
Non-Executive Director
Daniel Tasse
Non-Executive Director
Christian Stanton Schade
Non-Executive Director
Dr Andrew Thomas McLellan
Non-Executive Director
Tatjana Anni Hilde May
Non-Executive Director
Dr Yvonne Greenstreet
Non-Executive Director

Stock Details

EPIC
INDV
ISIN
GB00BRS65X63
Shares in Issue
728,441,653
Market cap
£1,500.59m

Analyst Views (3)

Strong Buy
 
66.67%
Buy
 
0.00%
Hold
 
33.33%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
202.30p
Bid Price
202.30p
Ask Price
202.80p
Volume
2847817
Change Today
-3.70p
% Change Today
-1.80%
Open
205.60p
Previous Close
202.30p
Intraday High
210.00p
Intraday Low
201.10p
52 Week High
504.60p
52 Week Low
169.30p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Indivior Intra-day Chart

Indivior News

News in this section is provided by MoneyAM

Broker Forecast - Jefferies International issues a broker note on Indivior Plc 11 Oct 2018 | 08:00 Indivior prepays $150m of outstanding debt 10 Sep 2018 | 07:41 Indivior says injunction upheld preventing generic sale of opioid treatment 31 Jul 2018 | 08:43 UK stocks reverse losses by the close 30 Jul 2018 | 16:26 FTSE struggles to gain momentum as investors ponder interest rate hikes 30 Jul 2018 | 11:41 FTSE falls ahead of interest rate meetings 30 Jul 2018 | 09:02 Indivior eyes launch of schizophrenia treatment as rival granted emergency appeal against injunction 30 Jul 2018 | 07:59 Broker Forecast - Numis issues a broker note on Indivior Plc 27 Jul 2018 | 09:10 Broker Forecast - Citigroup issues a broker note on Indivior Plc 26 Jul 2018 | 13:10 Latest twist in trade war saga weighs on UK and European markets 25 Jul 2018 | 16:43 Broker Forecast - Numis issues a broker note on Indivior Plc 25 Jul 2018 | 12:40 Indivior profits slip in H1, warns of 'materially higher' impact from copycat drug 25 Jul 2018 | 08:10 Broker Forecast - Citigroup issues a broker note on Indivior Plc 17 Jul 2018 | 08:40 Falling oil price hits FTSE 16 Jul 2018 | 16:46 FTSE falls ahead of key Brexit vote 16 Jul 2018 | 11:58 UK stocks open 0.1% lower amid China growth concerns 16 Jul 2018 | 09:03 Broker Forecast - Jefferies International issues a broker note on Indivior Plc 16 Jul 2018 | 08:40 Indivior granted preliminary injunction on generic opioid addiction treatment 16 Jul 2018 | 07:21 Global markets fall into the red as trade war concerns spread 11 Jul 2018 | 16:50 FTSE plummets on latest Trump tariff threat 11 Jul 2018 | 11:50 Broker Forecast - Numis issues a broker note on Indivior Plc 11 Jul 2018 | 09:50 Indivior warns on profits as competitors launch generic opioid addiction treatment 11 Jul 2018 | 07:54 Broker Forecast - Morgan Stanley issues a broker note on Indivior Plc 19 Jun 2018 | 09:20 Trade war worries cast a cloud once again over global markets 18 Jun 2018 | 16:37 FTSE dips on concerns over US-China trade war and tensions in Germany 18 Jun 2018 | 11:55 FTSE dips as weaker miners offset rising banks 18 Jun 2018 | 09:15 Indivior granted restraining order to temporarily stop Dr. Reddy's launch of generic Suboxone Film 18 Jun 2018 | 07:43 Global markets fall on reignited trade war fears 15 Jun 2018 | 16:47 Indivior seeks injunction after Dr. Reddy launches generic treatment for opioid misuse 15 Jun 2018 | 14:17 Broker Forecast - RBC Capital Markets issues a broker note on Indivior Plc 15 Jun 2018 | 11:10

Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Tangible Assets
54.0
27.0
Intangible Assets & Goodwill
92.0
83.0
Investments & Other Non-Current Assets
73.0
109.0
Total Non-Current Assets
219.0
219.0
Inventory
52.0
41.0
Trade & Receivables
278.0
227.0
Cash & Receivables
863.0
692.0
Other Current Assets & Assets Held for Resale
32.0
30.0
Total Assets
1,444.0
1,209.0

Liabilities (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Short Term Liabilities
854.0
1,030.0
Long Term Liabilities
793.0
474.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
1,647.0
1,504.0

Net Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Net Assets
-203.0
-295.0

Equity (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Share Capital
72.0
72.0
Minority Interests
0.0
0.0
Retained Earnings
1,032.0
950.0
Share Premium Account
2.0
0.0
Other Equity
-1,309.0
-1,317.0
Total Equity
-203.0
-295.0

Cashflow (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Cashflow from Operating Activities
295.0
407.0
Cashflow Before Financing
252.0
260.0
Increase / Decrease in Cash
168.0
225.0

Income (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Turnover
1,093.0
1,058.0
Cost of Sales
104.0
107.0
Gross Profit
989.0
951.0
Operating Profit
193.0
149.0
Pre-Tax Profit
137.0
98.0
Profit / Loss for the Year
58.0
35.0

Dividend History

Data has been provided by MoneyAM

Period
Ex-Dividend Date
Payment Date
H2 Dividend
16 Jun 2016
29 Jul 2016
H1 Dividend
17 Sep 2015
23 Oct 2015
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.